| 000 | 01486 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513113057.0 | ||
| 264 | 0 | _c19970328 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/89.5.395 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRibas, A | |
| 245 | 0 | 0 |
_aRe: Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cMar 1997 |
||
| 300 |
_a395-6 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aPlatelet Count _xdrug effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aAlbanell, J | |
| 700 | 1 | _aBellmunt, J | |
| 700 | 1 | _aSolé-Calvo, L A | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 89 _gno. 5 _gp. 395-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/89.5.395 _zAvailable from publisher's website |
| 999 |
_c9048901 _d9048901 |
||